Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9246522 | 1.00 | LMNA (0.32) | LMNA | |
| SCHEMBL5468793 | 0.83 | ACE2 (0.34) | — | |
| SCHEMBL6435230 | 0.81 | LMNA (0.37) | LMNA | |
| SCHEMBL3263623 | 0.79 | — | — | |
| SCHEMBL251689 | 0.79 | — | — | |
| SCHEMBL861285 | 0.79 | — | — | |
| SCHEMBL8517756 | 0.79 | — | — | |
| SCHEMBL9472172 | 0.78 | LMNA (0.35) | LMNA | |
| SCHEMBL9472557 | 0.77 | LMNA (0.37) | LMNA | |
| SCHEMBL9472524 | 0.77 | LMNA (0.37) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11602909-B2 | Tire sealant and tire repair kit | THE YOKOHAMA RUBBER CO., LTD. (JP) | 2023-03-14 | — | — | US | disclosed |
| US-20200086594-A1 | TIRE SEALANT AND TIRE REPAIR KIT | THE YOKOHAMA RUBBER CO., LTD. (JP) | 2020-03-19 | — | — | US | disclosed |
| EP-1505139-B2 | THICKENER, COSMETIC PREPARATION CONTAINING THE SAME, AND PROCESS FOR PRODUCING THE SAME | SHISEIDO CO LTD (JP) | 2014-06-18 | — | — | EP | disclosed |
| EP-1505139-B1 | THICKENER, COSMETIC PREPARATION CONTAINING THE SAME, AND PROCESS FOR PRODUCING THE SAME | SHISEIDO CO LTD (JP) | 2011-07-13 | — | — | EP | disclosed |
| US-20110098231-A1 | Skin Cosmetic | SHISEIDO COMPANY, LTD. (JP) | 2011-04-28 | — | — | US | disclosed |
| US-7927615-B2 | Thickener, cosmetic preparation containing the same, and process for producing the same | SHISEIDO COMPANY, LTD. (JP) | 2011-04-19 | — | — | US | disclosed |
| EP-2168568-A1 | SKIN COSMETIC | Shiseido Company, Limited (JP) | 2010-03-31 | — | — | EP | disclosed |
| US-20100029787-A1 | Thickener, Cosmetic Preparation Containing The Same, And Process For Producing The Same | SHISEIDO COMPANY, LTD. (JP) | 2010-02-04 | — | — | US | disclosed |
| US-20090258964-A1 | Skin Cosmetic | SHISEIDO COMPANY, LTD. (JP) | 2009-10-15 | — | — | US | disclosed |
| US-20050175564-A1 | Tickener, cosmetic preparation containing the same, and process for producing the same | SHISEIDO COMPANY, LTD. (JP) | 2005-08-11 | — | — | US | disclosed |
| EP-1505139-A1 | THICKENER, COSMETIC PREPARATION CONTAINING THE SAME, AND PROCESS FOR PRODUCING THE SAME | SHISEIDO COMPANY, LTD. (JP) | 2005-02-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050175564-A1 | Tickener, cosmetic preparation containing the same, and process for producing the same | TRHDE, FN1, SAMM50 | LMNA 2042/4885 |
| US-20090258964-A1 | Skin Cosmetic | CUTA, DEGS1, ALAD | LMNA 1367/4885 |
| US-20100029787-A1 | Thickener, Cosmetic Preparation Containing The Same, And Process For Producing The Same | POLD1, FASN, PCNA | LMNA 2162/4885 |
| US-20110098231-A1 | Skin Cosmetic | CUTA, DEGS1, ALAD | LMNA 1367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.